Deal closure is a procedural step with no new financial or strategic information. Monitor BioMarin's next earnings call for integration updates and any pipeline contributions from Alesta. No immediate trading catalyst.
Price Chart
Executive Summary
BioMarin completed its previously announced acquisition of Alesta Therapeutics B.V. on August 31, 2026, making Alesta a wholly owned subsidiary. The filing confirms deal closure but provides no financial terms, pipeline details, or strategic rationale, making it a routine administrative update with limited standalone trading impact.
Key Facts
- BioMarin completed the acquisition of Alesta Therapeutics B.V. on August 31, 2026.
- Alesta is now a wholly owned subsidiary of BioMarin.
- The acquisition was previously announced in an 8-K filed on August 18, 2026.
- No financial terms, deal value, or strategic details are disclosed in this filing.
Financial Impact
No financial terms disclosed in this filing.
Risk Factors
- Integration risk from the Alesta acquisition is unquantified.
- No disclosure of deal value or expected financial impact limits assessment of dilution or ROI.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-377696 |
| Document: 0001193125-26-377696-index-headers.html | 0001193125-26-377696 |
| Document: 0001193125-26-377696-index.html | 0001193125-26-377696 |
| Document: 0001193125-26-377696.txt | 0001193125-26-377696 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 8-K | $64.45 $63.94 | ▼ −0.79% | ▼ −1.61% | $57.65 (−10.55%) |
Sep 14, 2026 18d ago | 8-K | $66.41 $64.06 | ▼ −3.54% | ▼ −3.65% | $57.65 (−13.19%) |
Sep 1, 2026 4w ago | 8-K | $64.84 $64.41 | ▼ −0.66% | ▼ −0.74% | $57.65 (−11.09%) |
Sep 1, 2026 4w ago | Press Release | $64.84 $64.41 | ▼ −0.66% | ▼ −0.74% | $57.65 (−11.09%) |
Aug 31, 2026 4w ago | 8-K | $65.23 $64.63 | ▼ −0.92% | ▼ −0.78% | $57.65 (−11.62%) |
Aug 18, 2026 6w ago | 8-K | $66.99 $66.12 | ▼ −1.30% | ▼ −1.10% | $57.65 (−13.94%) |
Jun 4, 2026 17w ago | 8-K | $56.77 $55.95 | ▼ −1.44% | ▼ −2.01% | $57.65 (+1.55%) |
Apr 27, 2026 22w ago | 8-K | $53.62 $55.42 | ▲ +3.36% | ▲ +2.96% | $57.65 (+7.51%) |
Apr 21, 2026 23w ago | DEFA14A | $54.16 $53.24 | ▼ −1.71% | ▼ −1.76% | $57.65 (+6.44%) |
Feb 28, 2026 30w ago | Institutional Cluster | $59.71 $60.65 | ▲ +1.57% | ▲ +2.78% | $57.65 (−3.46%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access